Get the latest Science News and Discoveries

ESMO: 10-year survival data for lung cancer immunotherapy, new PSMA-targeted therapy for recurrent prostate cancer, promising results in metastatic colorectal and urothelial cancers - EurekAlert!


Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.

None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of Results

Results

Photo of cancers

cancers

Photo of targeted therapy

targeted therapy

Related news:

News photo

Smart jab can shrink head and neck cancer tumours within six weeks, trial finds. Triple-action therapy drug amivantamab could be given as an injection to help treat recurrent or metastatic cancers.

News photo

ESMO 2025: VT3989 continues to show promising early results in patients with advanced mesothelioma - EurekAlert!

News photo

ESMO 2025: mRNA-based COVID vaccines generate improved responses to immunotherapy - EurekAlert!